Skin and hard surface disinfection against Candida auris - What we know today
- PMID: 38384416
- PMCID: PMC10879571
- DOI: 10.3389/fmed.2024.1312929
Skin and hard surface disinfection against Candida auris - What we know today
Abstract
Candida auris has emerged as a global healthcare threat, displaying resistance to important healthcare antifungal therapies. Infection prevention and control protocols have become paramount in reducing transmission of C. auris in healthcare, of which cleaning and disinfection plays an important role. Candida albicans is used as a surrogate yeast for yeasticidal claims of disinfection products, but reports have been made that sensitivity to disinfectants by C. auris differs from its surrogate. In this review, we aimed to compile the information reported for products used for skin and hard surface disinfection against C. auris in its planktonic or biofilm form. A comparison was made with other Candida species, and information were gathered from laboratory studies and observations made in healthcare settings.
Keywords: Candida; Candida auris; hard-surface disinfection; skin disinfection; yeasticidal efficacy.
Copyright © 2024 Omardien and Teska.
Conflict of interest statement
SO and PT were employed by Diversey Holdings Ltd.
Similar articles
-
Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using European Standards EN 13624 and EN 16615.J Hosp Infect. 2020 Aug;105(4):648-656. doi: 10.1016/j.jhin.2020.05.026. Epub 2020 May 23. J Hosp Infect. 2020. PMID: 32454076
-
Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.J Hosp Infect. 2017 Dec;97(4):371-375. doi: 10.1016/j.jhin.2017.08.019. Epub 2017 Sep 1. J Hosp Infect. 2017. PMID: 28865738
-
Different efficacies of common disinfection methods against candida auris and other candida species.J Infect Public Health. 2020 May;13(5):730-736. doi: 10.1016/j.jiph.2020.01.008. Epub 2020 Jan 28. J Infect Public Health. 2020. PMID: 32005617
-
Candida auris: Disinfectants and Implications for Infection Control.Front Microbiol. 2018 Apr 12;9:726. doi: 10.3389/fmicb.2018.00726. eCollection 2018. Front Microbiol. 2018. PMID: 29706945 Free PMC article. Review.
-
Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris.Front Microbiol. 2019 Nov 29;10:2788. doi: 10.3389/fmicb.2019.02788. eCollection 2019. Front Microbiol. 2019. PMID: 31849919 Free PMC article. Review.
Cited by
-
Candida auris Metabolism and Growth Preferences in Physiologically Relevant Skin-like Conditions.bioRxiv [Preprint]. 2025 May 19:2025.05.18.654780. doi: 10.1101/2025.05.18.654780. bioRxiv. 2025. PMID: 40475518 Free PMC article. Preprint.
-
Candida auris Outbreaks: Current Status and Future Perspectives.Microorganisms. 2024 May 1;12(5):927. doi: 10.3390/microorganisms12050927. Microorganisms. 2024. PMID: 38792757 Free PMC article. Review.
-
Octenidine effectively reduces Candida auris colonisation on human skin.Sci Rep. 2025 Jul 25;15(1):27034. doi: 10.1038/s41598-025-11914-x. Sci Rep. 2025. PMID: 40715367 Free PMC article.
-
A Novel and Robust Method for Investigating Fungal Biofilm.Bio Protoc. 2025 Jan 5;15(1):e5146. doi: 10.21769/BioProtoc.5146. eCollection 2025 Jan 5. Bio Protoc. 2025. PMID: 39803325 Free PMC article.
-
The multidrug-resistant Candida auris, Candida haemulonii complex and phylogenetic related species: Insights into antifungal resistance mechanisms.Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025. Curr Res Microb Sci. 2025. PMID: 39995443 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources